These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20422599)

  • 1. Field vaccination of sheep with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9: effect on milk production.
    Savini G; Monaco F; Facchinei A; Pinoni C; Salucci S; Cofini F; Di Ventura M
    Vet Ital; 2004; 40(4):627-30. PubMed ID: 20422599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field vaccination of cattle using a bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9: effect on milk production.
    Monaco F; De Luca N; Morelli D; Pisciella M; Palmarini S; Di Giandomenico M; Savini G
    Vet Ital; 2004; 40(4):661-3. PubMed ID: 20422607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination of cattle using monovalent modified-live vaccine against bluetongue virus serotype 2: innocuity, immunogenicity and effect on pregnancy.
    Monaco F; Bonfini B; Zaghini M; Antonucci D; Pini A; Savini G
    Vet Ital; 2004; 40(4):671-5. PubMed ID: 20422610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virological and serological response of cattle following field vaccination with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9.
    Monaco F; De Luca N; Spina P; Morelli D; Liberatore I; Citarella R; Conte A; Savini G
    Vet Ital; 2004; 40(4):657-60. PubMed ID: 20422606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virological and serological response of sheep following field vaccination with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9.
    Savini G; Monaco F; Conte A; Migliaccio P; Casaccia C; Salucci S; Di Ventura M
    Vet Ital; 2004; 40(4):631-4. PubMed ID: 20422600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monovalent modified-live vaccine against bluetongue virus serotype 2: immunity studies in cows.
    Savini G; Monaco F; Citarella R; Calzetta G; Panichi G; Ruiu A; Caporale V
    Vet Ital; 2004; 40(4):664-7. PubMed ID: 20422608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological response in cattle and sheep following infection or vaccination with bluetongue virus.
    Savini G; Tittarelli M; Bonfini B; Zaghini M; Di Ventura M; Monaco F
    Vet Ital; 2004; 40(4):645-7. PubMed ID: 20422603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16.
    Savini G; Cannas A; Casaccia C; Di Gialleonardo L; Leone A; Patta C; Nicolussi P
    Vet Microbiol; 2010 Nov; 146(1-2):44-50. PubMed ID: 20537822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vaccination against bluetongue on milk production and quality in cattle vaccinated with live-attenuated monovalent type 2 vaccine.
    Giovannini A; Conte A; Panichi G; Calistri P; Dessì M; Foddis F; Schintu A; Caporale V
    Vet Ital; 2004; 40(4):648-53. PubMed ID: 20422604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bivalent bluetongue virus serotypes 2 and 9 vaccine on reproductive performance of cattle: a case study in Calabria, Italy.
    Lucifora G; Rossi P; Calistri P; Giovannini A
    Vet Ital; 2004; 40(4):654-6. PubMed ID: 20422605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
    Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
    Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between field and vaccine strain of bluetongue virus serotype 16.
    Monaco F; Cammà C; Serini S; Savini G
    Vet Microbiol; 2006 Aug; 116(1-3):45-52. PubMed ID: 16713688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the minimum protective dose for bluetongue virus serotype 2 and 8 vaccines in sheep.
    Modumo J; Venter EH
    J S Afr Vet Assoc; 2012 Aug; 83(1):17. PubMed ID: 23327131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety studies on an inactivated vaccine against bluetongue virus serotype 2.
    Di Emidio B; Nicolussi P; Patta C; Ronchi GF; Monaco F; Savini G; Ciarelli A; Caporale V
    Vet Ital; 2004; 40(4):640-4. PubMed ID: 20422602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular differentiation of field and vaccine strains of bluetongue virus serotype 2 using the real-time polymerase chain reaction and fluorescene resonance energy transfer hybridisation probes.
    de Santis P; Orrù G; Solinas F; Piras V; Savini G; Caporale V
    Vet Ital; 2004; 40(4):572-6. PubMed ID: 20422589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DIVA system based on the detection of antibodies to non-structural protein 3 (NS3) of bluetongue virus.
    Barros SC; Cruz B; Luís TM; Ramos F; Fagulha T; Duarte M; Henriques M; Fevereiro M
    Vet Microbiol; 2009 Jun; 137(3-4):252-9. PubMed ID: 19233575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a quadrivalent modified-live bluetongue virus vaccine in wildlife species.
    McConnell S; Morrill JC; Livingston CW
    Prog Clin Biol Res; 1985; 178():631-8. PubMed ID: 2989912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication of live-attenuated vaccine strains of bluetongue virus in orally infected South African Culicoides species.
    Venter GJ; Mellor PS; Wright I; Paweska JT
    Med Vet Entomol; 2007 Sep; 21(3):239-47. PubMed ID: 17897364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically engineered structure-based vaccine for bluetongue disease.
    Roy P
    Vet Ital; 2004; 40(4):594-600. PubMed ID: 20422594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.